Underutilized Pharma Services And Execution Risks Will Threaten Demand Yet Efficiency Will Emerge

Published
07 Aug 25
Updated
10 Aug 25
AnalystLowTarget's Fair Value
US$6.50
10.5% undervalued intrinsic discount
10 Aug
US$5.82
Loading
1Y
-63.5%
7D
2.6%

Author's Valuation

US$6.5

10.5% undervalued intrinsic discount

AnalystLowTarget Fair Value